![](/wp-content/uploads/2019/06/fenix-group-announcement.png)
$599
New Trulicity Label Update: lower hypo cutoff, AWARD-10, and pre-filled syringe discontinuation
The Trulicity label has recently been updated with 3 major changes: 1) lower rates of hypoglycemia based on moving the cutoff from <70mg/dL to <54mg/dL, 2) inclusion of AWARD-10 data (add-on to SGLT2i), and 3) discontinuation of the pre-filled syringes. Below, FENIX provides analysis of the Trulicity label update including a focus on the broader market implications of lowering the hypo cutoff. Trulicity hypo label data improves competitive messaging vs. Ozempic The Trulicity label was updated with new, lower hypo rates using a lower hypo cutoff to match Ozempic and Bydureon. In the old Trulicity label, the cutoff was high……